These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18589556)

  • 21. Bioequivalence study with two different oral formulations of methocarbamol in healthy subjects. A mono-centre, comparative, randomized, open-label, single-dose, 2-way crossover study.
    Schlegelmilch R; Eydeler AU; Barkworth M; Radeke A
    Arzneimittelforschung; 2009; 59(5):238-42. PubMed ID: 19537524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients.
    Macdougall IC; Gray SJ; Elston O; Breen C; Jenkins B; Browne J; Egrie J
    J Am Soc Nephrol; 1999 Nov; 10(11):2392-5. PubMed ID: 10541299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and bioequivalence study of clindamycin hydrochloride formulations after single-dose administration in healthy Chinese male volunteers.
    Li J; Wang N; Zhang ZJ; Tian Y; Tang W; Chen Y
    Arzneimittelforschung; 2008; 58(7):358-62. PubMed ID: 18751503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and bioequivalence study of aniracetam after single-dose administration in healthy Chinese male volunteers.
    Tian Y; Zhang JJ; Feng SD; Zhang ZJ; Chen Y
    Arzneimittelforschung; 2008; 58(10):497-500. PubMed ID: 19025058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioequivalence studies of omnitrope, the first biosimilar/rhGH follow-on protein: two comparative phase 1 randomized studies and population pharmacokinetic analysis.
    Stanhope R; Sörgel F; Gravel P; Pannatier Schuetz YB; Zabransky M; Muenzberg M
    J Clin Pharmacol; 2010 Nov; 50(11):1339-48. PubMed ID: 20173088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after multiple subcutaneous doses in healthy subjects.
    Krzyzanski W; Jusko WJ; Wacholtz MC; Minton N; Cheung WK
    Eur J Pharm Sci; 2005 Nov; 26(3-4):295-306. PubMed ID: 16102948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioequivalence of two subcutaneous pharmaceutical products of interferon beta la.
    Di Girolamo G; Kauffman MA; González E; Papouchado M; Ramírez A; Keller G; Carbonetto C; Dabsys S; Vidal A; Sterin-Prync A; Diez RA
    Arzneimittelforschung; 2008; 58(4):193-8. PubMed ID: 18540482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Truncated areas under the curve in the assessment of pioglitazone bioequivalence. Data from a single-center, single-dose, randomized, open-label, 2-way cross-over bioequivalence study of two formulations of pioglitazone 45 mg tablets under fasting conditions.
    Almeida S; Filipe A; Neves R; Pinho C; Pedroso P; Castillo A; Trabelsi F
    Arzneimittelforschung; 2011; 61(1):32-9. PubMed ID: 21355444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and comparative bioavailability of two terbinafine hydrochloride formulations after single-dose administration in Chinese healthy subjects.
    Jiang X; Wang N; Zhang ZJ; Tian Y; Chen Y
    Arzneimittelforschung; 2008; 58(7):363-6. PubMed ID: 18751504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphatic absorption is the primary contributor to the systemic availability of epoetin Alfa following subcutaneous administration to sheep.
    McLennan DN; Porter CJ; Edwards GA; Martin SW; Heatherington AC; Charman SA
    J Pharmacol Exp Ther; 2005 Apr; 313(1):345-51. PubMed ID: 15579493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epoetin alfa for the treatment of the anemia of multiple myeloma. A prospective, randomized, placebo-controlled, double-blind trial.
    Garton JP; Gertz MA; Witzig TE; Greipp PR; Lust JA; Schroeder G; Kyle RA
    Arch Intern Med; 1995 Oct; 155(19):2069-74. PubMed ID: 7575066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Switching epoetin alfa and epoetin zeta in patients with renal anemia on dialysis: Posthoc analysis.
    Więcek A; Ahmed I; Scigalla P; Koytchev R
    Adv Ther; 2010 Dec; 27(12):941-52. PubMed ID: 20972656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and bioequivalence study of valacyclovir hydrochloride capsules after single dose administration in healthy Chinese male volunteers.
    Lin H; Tian Y; Tian JX; Zhang ZJ; Mao GG
    Arzneimittelforschung; 2010; 60(3):162-7. PubMed ID: 20422949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and bioequivalence study of a generic amlodipine tablet formulation in healthy male volunteers.
    Sailer R; Arnold P; Erenmemişoğlu A; Martin W; Tamur U; Kanzik I; Hincal AA
    Arzneimittelforschung; 2007; 57(7):462-6. PubMed ID: 17803059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacodynamic and Pharmacokinetic Equivalences of Epoetin Hospira and Epogen(®) After Multiple Subcutaneous Doses to Healthy Male Subjects.
    Stalker D; Ramaiya A; Kumbhat S; Zhang J; Reid S; Martin N
    Clin Ther; 2016 May; 38(5):1090-101. PubMed ID: 27112531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioequivalence of HX575 (recombinant human epoetin alfa) and a comparator epoetin alfa after multiple subcutaneous administrations.
    Sörgel F; Thyroff-Friesinger U; Vetter A; Vens-Cappell B; Kinzig M
    Pharmacology; 2009; 83(2):122-30. PubMed ID: 19122476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcutaneous compared with intravenous epoetin in patients receiving hemodialysis. Department of Veterans Affairs Cooperative Study Group on Erythropoietin in Hemodialysis Patients.
    Kaufman JS; Reda DJ; Fye CL; Goldfarb DS; Henderson WG; Kleinman JG; Vaamonde CA
    N Engl J Med; 1998 Aug; 339(9):578-83. PubMed ID: 9718376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative pharmacokinetics, safety, and tolerability after subcutaneous administration of recombinant human erythropoietin formulated with different stabilizers.
    Cheung WK; Natarajan J; Sanders M; Vercammen E
    Biopharm Drug Dispos; 2000 Sep; 21(6):211-9. PubMed ID: 11304719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers.
    Darwish M; Chang S; Hellriegel ET
    Clin Ther; 2009 Jan; 31(1):108-14. PubMed ID: 19243711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.